Malayalam Daily Press: Zim Laboratories to be listed on BSE tomorrow

Nagpur-based pharmaceuticals company Zim Laboratories will list on BSE on Friday, June 8.
Zim Labs was trading on the OTC Exchange Of India before the Securities Exchange Board of India (SEBI) withdrew its recognition of it in March 2015.

The company was recently by allowed SEBI to list on the main board of BSE.  This listing will provide an exit to some of its existing shareholders.

The book value of Zim Labs, promoted by Anwar Daud, is Rs 160 per equity share.
Daud and his family own 54 percent stake in the company, and private equity firm Ashmore Alchemy India Advisors owns around 22 percent. The rest is owned by minority shareholders.

Original Article 


Popular posts from this blog

ZIMLab's Dr.Nidhi Sapkal delivered talk on "Technology development of Bi/Multilayer thin films" at International Conference on Pharmaceutical Development and Technology,Osaka, Japan.

ZIM Lab announces approval for Vitamin D3 Orally Disintegrating Film

ZIM’s exclusive Oral Thin Film manufacturing technology - ‘Thinoral®’